PUBLIC POLICY FORUM “Marijuana: Problems and Opportunities in New York State” NYSAM 11th ANNUAL STATEWIDE CONFERENCE “INTERSECTION OF SCIENCE, TREATMENT AND POLICY” This conference, which has been designed for physicians, medical students, residents, and fellows, features stateof-the-art presentations highlighting the most recent developments in addiction medicine. Friday, January 30, 2015 8:00 am - 8:15 am Welcome and Introductions 8:15 am - 9:00 am Effects of Marijuana on Adolescents Timothy Brennan, MD, MPH, Addiction Institute of New York This presentation will review the currently published scientific literature regarding the effects of marijuana on adolescents. It will highlight the facts (and only the facts), regarding what we currently know about marijuana and adolescents. 9:00 am - 9:45 am Approaches to Treatment for Marijuana Use Disorders in Youth Marc Fishman, MD, John Hopkins Adolescents are particularly vulnerable to the problematic effects of marijuana use, including the development of marijuana use disorders (MUDs) in the addiction spectrum. There is considerable evidence for the effectiveness of several treatment approaches for MUDs in youth, as well as other promising approaches with emerging support. Given current societal ambivalence about the risks of marijuana use and the associated decrease in perceived harm among youth and their families, enhancement of motivation and treatment engagement are the most important targets for improving effectiveness. 9:45 am - 10:15 am Adolescent Addiction Treatment in New York Greg Bunt, MD, Daytop Village, President of NYSAM Steven Hanson, NYS OASAS William A. Fusco, Executive Director, Dynamic Youth Community, Inc. Carol Ann Slattery, EdD, LCSW-R, Assistant Vice President, Outpatient Services, Samaritan Village Adolescent addiction is an important focus in NY. This presentation will describe the current state as well a planned changes in the delivery of addiction services to youth. Medicaid Redesign, Program opportunities, level of care determination, care coordination and use of evidence based practices will be included in the discussion. Particular attention will be paid to marijuana use and treatment. 10:15 am - 10:30 am 10:30 am - 11:15 am Break Legal Ramifications of Marijuana Arrests for Juveniles Sandeep Kandhari, JD, NYC Legal Aid Society Sandeep Kandhari is an Assistant Attorney-in-Charge with the Legal Aid Society’s Juvenile Rights Practice. Mr. Kandhari will share insight from his experiences representing juveniles both in the adult and juvenile system. The presentation will include a description of how marijuana cases proceed in the justice system and the consequences of prosecuting juveniles for marijuana possession. 11:15 am - 12:00 pm Discouraging Marijuana Consumption by Young People: Lessons from Tobacco Control Allyn Taylor, JD, JSD, Affiliate Professor of Law, University of Washington School of Law As an increasing number of states decriminalize or legalize marijuana, strategies must be developed to prevent promotion of and discourage consumption by young people. This presentation will consider lessons that can be learned from widely used tobacco regulatory strategies, including prohibitions and restrictions on tobacco advertising, promotion and sales to young people. Friday, January 30, 2015 12:00 pm - 1:15 pm 1:15 pm - 2:00 pm Lunch—Non CME Topic Tables Medical Marijuana: What Do We Know? Brian F. Sands, MD, Assistant Clinical Professor, Department of Psychiatry, New York University School of Medicine Marijuana has been cultivated and used by human beings for at least a millennium. Consideration of it’s legitimate uses as a therapeutic agent have been complicated by the social and, therefore, legal perspective of recreational marijuana use. Although a large segment of the US population use this drug recreationally, use is a crime (except recently in some states) and research has been constrained. There are a number of potential indications for marijuana and a less restrictive research environment could help us understand it’s role as a pharmaceutical agent. Because of the social and legal context, leaders in several states have passed legislation, which has put marijuana in a unique position among pharmaceuticals. 2:00 pm - 2:45 pm Finding the Medicine in Marijuana: New Developments in Cannabinoid Medications Stephen Schultz, Vice President, Investor Relations, GW Pharmaceuticals For centuries, many cultures and societies have utilized the cannabis plant for therapeutic purposes. However, the development of cannabinoid and cannabis-derived medications has not kept pace with that of other modern prescription products, such as opioids. Only in the last two decades have scientists uncovered the mechanism of action by which cannabinoids affect the human brain and body. It is well known that tetrahydrocannabinol (THC) is psychoactive and can produce unacceptable CNS side effects. However, different formulations of cannabinoids and different delivery systems may affect the risk/benefit profile of cannabinoid and cannabis-derived products. Recent clinical research has produced intriguing results, and further study is underway to elucidate more fully the analgesic and other therapeutic potential of these medications. 2:45 pm - 3:00 pm Break 3:00 pm - 4:00 pm Implementation of the Compassionate Care Act in New York State Sandi Toll, Assistant Counsel to the Governor New York State will soon be enhancing healthcare for person suffering from a number of serious health conditions when we implement Compassionate Care Act. To guide that implementation, draft regulations have been developed and will be finalized with considerable input from diverse stakeholders. This plenary will provide an update on New York State’s readiness for implementation of the Compassionate Care Act and an overview of the work that remains. 4:00 pm - 4:30 pm Video on Tobacco and Marijuana Promotion 4:30 pm - 5:00 pm Prevention and Primary Care Approaches Norman Wetterau, MD Drug and alcohol use and abuse are a contagious pediatric problem. We need to address this early as we do other diseases rather than wait until there is full-blown addiction. There are evidence based methods of prevention. There are screening instruments that primary care practices can use and early interventions but these are time consuming. With the development of integrated health care systems evidence based prevention and early interventions could be incorporated into primary care practices. ASAM members should be leaders in these affords. 5:15 pm - 6:30 pm 6:30 pm Annual NYSAM Meeting Networking Reception